Skip to main content
Total Market Cap: $48,318,152,223 Volume (24h): $759,890,024

Cara Therapeutics Inc.

Cara Therapeutics Inc. (CARA) logo
Rank 19
About

Cara Therapeutics is a biopharmaceutical company that focuses on the development of compound-based treatments for pain, inflammation, and pruritus. Several of its products are in the preclinical stage of development, including KORSUVA, oral KORUSUVA, and CR845/CR701. While the company is based in Stamford, Connecticut, it has plans to expand into Asian markets.

Website
$9.8400
USD
-4.34%
Market cap
$456,750,168
Total volume
$4,098,842
Shares outstanding
46,417,700
Rank 19
Website
About

Cara Therapeutics is a biopharmaceutical company that focuses on the development of compound-based treatments for pain, inflammation, and pruritus. Several of its products are in the preclinical stage of development, including KORSUVA, oral KORUSUVA, and CR845/CR701. While the company is based in Stamford, Connecticut, it has plans to expand into Asian markets.

Markets
Exchange Symbol Volume (24h) Volume (%) Price
Nasdaq
CARA
$4,098,842
100%
$9.8400
Chart
Social media

Share widget

Copy widget code
Subscribe to our newsletter